Oryza Pharmaceuticals Inc

FDA Filings

This page includes the latest FDA filings for Oryza Pharmaceuticals Inc. Currently, you will find the latest 100 filings for Premarket Notifications, Premarket Applications, De Novo Applications, and GUDID registrations.

FDA Registration(s)

• Registration Number: 0
• FEI Number: 0
• Name: ORYZA PHARMACEUTICALS INC
• Owner & Operator: ORYZA PHARMACEUTICALS INC
• Official Correspondent:
  • BANG QIAN XU
  • 1-609-7215985-x
• Registration Status: 5
• Initial Importer: Y
• Registration Expiration: 2020-04-25
• Registration Address: 4117 Northwest 124th Avenue ; Coral Springs, FL 33065 US

FDA Filings

Device Company	Device	Date
Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate Oryza Pharmaceuticals Inc., USpharma Ltd.	Prescription Medication	2024-04-18
Papaverine Hydrochloride Oryza Pharmaceuticals Inc.	Prescription Medication	2023-02-10
Metoprolol Succinate Oryza Pharmaceuticals, Inc, Visum Pharmaceutical Co., Ltd.	Prescription Medication	2022-08-27
Metoprolol Succinate Oryza Pharmaceuticals, Inc, Visum Pharmaceutical Co., Ltd.	Prescription Medication	2022-05-06
NDC 72516-033 Oryza Pharmaceuticals, Inc	Metoprolol Succinate	2022-04-27
NDC 72516-032 Oryza Pharmaceuticals, Inc	Metoprolol Succinate	2022-04-27
NDC 72516-031 Oryza Pharmaceuticals, Inc	Metoprolol Succinate	2022-04-27
NDC 72516-030 Oryza Pharmaceuticals, Inc	Metoprolol Succinate	2022-04-27
Papaverine Hydrochloride Oryza Pharmaceuticals Inc.	Prescription Medication	2021-02-10
NDC 72516-024 Oryza Pharmaceuticals Inc.	Papaverine Hydrochloride	2021-02-01
Papaverine Hydrochloride Oryza Pharmaceuticals Inc.	Prescription Medication	2021-02-01
Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate Oryza Pharmaceuticals Inc., USpharma Ltd.	Prescription Medication	2020-10-27
NDC 72516-016 Oryza Pharmaceuticals Inc.	Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate And Amphetamine Sulfate	2020-10-19
NDC 72516-015 Oryza Pharmaceuticals Inc.	Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate And Amphetamine Sulfate	2020-10-19
NDC 72516-014 Oryza Pharmaceuticals Inc.	Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate And Amphetamine Sulfate	2020-10-19
NDC 72516-013 Oryza Pharmaceuticals Inc.	Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate And Amphetamine Sulfate	2020-10-19
NDC 72516-012 Oryza Pharmaceuticals Inc.	Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate And Amphetamine Sulfate	2020-10-19
NDC 72516-011 Oryza Pharmaceuticals Inc.	Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate And Amphetamine Sulfate	2020-10-19

Similar & Related FDA Registered Companies

• USpharma Ltd.
• Visum Pharmaceutical Co., Ltd.